Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | FGF5 |
| Upstream (Parents) |
|---|
| (<<) CAV3 → FGF5 |
| (<<) CEND1 → FGF5 |
| (<<) CHAC1 → FGF5 |
| (<<) CRTC1 → FGF5 |
| (<<) CYP1A2 → FGF5 |
| (<<) FZD4 → FGF5 |
| (<<) GALR3 → FGF5 |
| (<<) GDNF → FGF5 |
| (<<) GNAI1 → FGF5 |
| (<<) HS2ST1 → FGF5 |
| (<<) NDOR1 → FGF5 |
| (<<) PHLDA2 → FGF5 |
| (<<) PLA2G6 → FGF5 |
| (<<) PTGER1 → FGF5 |
| (<<) T → FGF5 |
| Downstream (Children) |
|---|
| FGF5 → DYRK1A (>>) |
| FGF5 → KRT75 (>>) |
| FGF5 → ORM1 (>>) |
| FGF5 → UST (>>) |
| FGF5 → WNT6 (>>) |
